Brother Tian talks about liver and gallbladder | Wu Mengda died of liver cancer, is hepatitis B the "man behind the scenes"?

Recently, Hong Kong actor Wu Mengda and well-known mainland musician Zhao Yingjun died of liver cancer, and liver cancer has once again become the focus of attention.

China is a major liver cancer country.
In 2020, there are 910,000 new cases of liver cancer in the world, of which 410,000 new cases of liver cancer in China, accounting for 45% of the world.

In terms of global liver cancer mortality, China is also the world's first.
In 2020, there will be 830,000 liver cancer deaths worldwide, of which 390,000 will die from liver cancer in China.

Screening of high-risk groups of liver cancer is helpful for early detection, early diagnosis and early treatment of liver cancer, and is the key to improving the efficacy of liver cancer.

In my country, people at high risk of liver cancer mainly include: Hepatitis B virus (HBV) and/or Hepatitis C virus (HCV) infection, excessive drinking, non-alcoholic steatohepatitis, long-term consumption Foods contaminated with aflatoxin, liver cirrhosis caused by various other causes, and people with a family history of liver cancer, especially men >40 years old, are at greater risk.

Chronic HBV infection is the main cause of liver cancer in my country.
Among patients with liver cirrhosis and primary liver cancer in China, HBV causes 77% and 84%, respectively.

It is recommended to use liver ultrasound and serum alpha-fetoprotein (Alpha-fetoprotein, AFP) for early screening for liver cancer, and for high-risk groups at least once every 6 months.

Expert profile Prof.
Yang Tian Deputy Chief Physician, Associate Professor, Master Supervisor of Hepatobiliary Surgery, Shanghai Oriental Hepatobiliary Surgery Hospital Official member of the International Hepatobiliary and Pancreatic Association (IHPBA) Academic Committee Secretary of the International Hepatobiliary and Pancreatic Association (CC-IHPBA) Chinese Society of Clinical Oncology (CSCO) ) Standing Member of the Youth Committee, Member of the Liver Cancer Expert Committee, World J Clin Oncol, Senior Visiting Scholar, Mount Sinai School of Medicine, New York, United States, Associate Editor of Gut Chinese Edition Liver Special Edition, Specially Invited Reviewer of Journals such as Lancet, BMJ, JCO, Am J Gastroenterol, HPB , World Journal of Hepatology, Hepatic Oncology, "Chinese Journal of Digestive Surgery", "Chinese Journal of Experimental Surgery" and other 16 professional journals editorial board Shanghai Outstanding Young Medical Talent, Shanghai Pujiang Talent, Shanghai Young Top Talent, Shanghai Youth Star of science and technology, outstanding young talents of Shanghai health system, outstanding professional and technical personnel of the military, the first good doctor of the people "Golden Camellia" Outstanding Contribution Award (Gold Award), the first/corresponding author published 80 SCI articles, total IF score>400, Single IF>10 points 8 articles, maximum 27.
40 points (cover article) presided over 4 National Natural Science Foundation of China, 8 provincial and ministerial funds